The Centre Of Research Excellence On Achieving The Tobacco Endgame (CREATE)
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
The Centre of Research Excellence on Achieving the Tobacco Endgame (CREATE) will develop a strategy to make Australia smoke-free. Our multi-disciplinary research will determine which strategies are the most effective, equitable and acceptable to the public and policymakers. We will identify the barriers and enablers, and make recommendations on the optimal suite of policies to end the cigarette epidemic and reduce the healthcare burden associated with smoking related diseases.
Smoking Cessation For Youth Project Booster And Cohort Tracking Study
Funder
National Health and Medical Research Council
Funding Amount
$135,550.00
Summary
Adolescence is a critical period for the establishment of adult drug use behaviours. If smoking does not commence in teenage years it is unlikely to occur. This innovative project not only continues to address tobacco control with this important age group but also builds on evidence from a randomised intervention trial involving over 4,000 Year 9 students tracked over two years. This project was called the Smoking Cessation for Youth Project (SCYP). Preliminary longitudinal analyses of the SCYP ....Adolescence is a critical period for the establishment of adult drug use behaviours. If smoking does not commence in teenage years it is unlikely to occur. This innovative project not only continues to address tobacco control with this important age group but also builds on evidence from a randomised intervention trial involving over 4,000 Year 9 students tracked over two years. This project was called the Smoking Cessation for Youth Project (SCYP). Preliminary longitudinal analyses of the SCYP data indicate that the intervention students were significantly less likely to smoke heavily (smoking five or more days per week) than the control group and that intervention students were also significantly less likely to have tried smoking than the control group. These results represent a world first in evidence that population-based smoking cessation interventions among teenagers can be successful. The proposed project will determine the extent to which these positive intervention effects are sustainable, two years post intervention, as our cohort moves into Year 12. In addition to tracking the possible decay of SCYP intervention effects, the proposed project will also measure the effects of a booster intervention delivered students when they are in Year 12 (2002). The Year 12 intervention will comprise an innovative self-help 'magazine style' booster and a supportive environmental intervention involving school nurses and local GPs. This proposal represents a cost-effective opportunity to measure the effectiveness of a Year 12 tobacco cessation booster intervention. Further data on tobacco smoking behaviour in 2002 will also enable us to determine how long the SCYP intervention appears to affect behaviour and whether 'boosters' are needed in later secondary school years to maintain the benefits.Read moreRead less
Unintended Adverse Effects Of Advertising For Nicotine Replacement Therapies
Funder
National Health and Medical Research Council
Funding Amount
$133,250.00
Summary
Advertising for certain pharmaceutical products (nicotine replacement therapy( NRT)) to help people quit smoking has been permitted in Australia since 1997. Zyban, an antidepressant drug, has been found to be helpful in quitting smoking, but advertising has not yet been permitted in Australia although it is allowed overseas. Because such advertising will reach more than the primary target group of heavy smokers ready to quit, it is important to consider the responses of other smokers who are not ....Advertising for certain pharmaceutical products (nicotine replacement therapy( NRT)) to help people quit smoking has been permitted in Australia since 1997. Zyban, an antidepressant drug, has been found to be helpful in quitting smoking, but advertising has not yet been permitted in Australia although it is allowed overseas. Because such advertising will reach more than the primary target group of heavy smokers ready to quit, it is important to consider the responses of other smokers who are not ready to quit and those at risk of taking up smoking. There is concern that there may be 'boomerang' effects, albeit unintended, on these population groups, because they may feel reassured that there is an effective method to quit and so be in no rush to quit soon, they may try to quit using these products before they are really ready, and in the case of teenagers, they may think that these products make it easy to quit, so there is less problem with starting to smoke. In order to assess if this is so, we will randomly allocate smokers not yet ready to quit and teenagers to either (a) a group where they view 3 ads promoting non-drug methods of quitting, such as the Quitline, (b) a group where they view 3 ads promoting the NRT gum or patch, or (c) a group where they view 3 ads promoting Zyban as a method for quitting. The study will use questionnaires to assess whether, compared with those viewing the non-drug anti-smoking ads, those viewing the NRT or Zyban ads think smoking is less addictive and have less intention to quit, or in the case of teenagers, have more intention to take up smoking. This project will be the first formal study to assess whether there may be adverse effects of NRT and Zyban advertising on smokers not yet ready to quit and teenagers who are not already regular smokers. For this reason, the study will help an assessment of the risks of such advertising compared with the established benefits for smokers who are ready to quit.Read moreRead less
An Open-label Randomised Pragmatic Policy Trial Of Nicotine Products For Short-term Cessation Assistance Or Long-term Substitution In Smokers.
Funder
National Health and Medical Research Council
Funding Amount
$1,053,910.00
Summary
Many smokers who try to quit fail in their attempt. Medicinal nicotine is currently only used as a short-term quit aid. This trial will test if offering smokers the option of using these products as long-term substitutes for cigarettes will help more smokers to successfully quit. We will also determine if offering smokers low toxicity smokeless tobacco and electronic nicotine devices in addition to medicinal nicotine products further increases the number of smokers who quit successfully.
Community Action For Smoking Cessation In Remote Aboriginal Communities
Funder
National Health and Medical Research Council
Funding Amount
$1,162,650.00
Summary
Smoking rates halved in Australia over the past 30 years to below 20% in 2004. However, Indigenous Australians continued to smoke at more than double this rate. In remote Aboriginal communities in the NT's 'Top End', over two-thirds of the population smoke. Smoking tobacco causes the greatest burden of disease for Australians generally. For Indigenous Australians, it is the single most important reversible risk factor for morbidity and premature mortality. With no sign of reduction in smoking le ....Smoking rates halved in Australia over the past 30 years to below 20% in 2004. However, Indigenous Australians continued to smoke at more than double this rate. In remote Aboriginal communities in the NT's 'Top End', over two-thirds of the population smoke. Smoking tobacco causes the greatest burden of disease for Australians generally. For Indigenous Australians, it is the single most important reversible risk factor for morbidity and premature mortality. With no sign of reduction in smoking levels, Indigenous Australians remain at greater risk of hospitalisations or death from many tobacco-related illnesses. Smoking in Australia was reduced through individually-oriented measures, public education and supply control. These strategies have either not been tried or have not been adequately studied in Aboriginal communities. Effective interventions could provide major health gains for Aboriginal Australians and reduce health costs. The intervention we propose will be based on an agreement whereby four remote communities in the 'Top End' will make a pact with the researchers to jointly try to reduce tobacco smoking using community-wide mobilisation, training and education. The intervention with have multiple components. We will not evaluate each component separately. The effect of the whole intervention on smoking will be assessed. Tobacco sales for the whole community in these small isolated localities, a sensitive and reliable measure, should decline if the intervention works. Tobacco smokers will be assessed before the intervention in each community and followed up twice to assess quit rates. Quit rates should go up. Five years are needed for the study because smoking behaviour change does not happen quickly or at peoples' first attempt. With staggered implementation of the intervention, i.e. not starting in all communities at once, reductions in smoking in more than one community will make us confident that the intervention worked.Read moreRead less
Low-yield Cigarettes And Diminution Of Small Airways Lung Function In Long-term Smokers
Funder
National Health and Medical Research Council
Funding Amount
$209,500.00
Summary
The modern cigarette has been designed to produce low yields of tar when the tobacco in the cigarette is burnt. The tar contains human carcinogens, and monitoring and regulating yields of tar has long been part of the comprehensive tobacco control strategy in Australia. This focus on tar has given an implicit endorsement of the low-yield cigarette as a safer cigarette. Recently, however, controversy has emerged about whether smoking low-yield cigarettes has reduced the harm done by smoking. The ....The modern cigarette has been designed to produce low yields of tar when the tobacco in the cigarette is burnt. The tar contains human carcinogens, and monitoring and regulating yields of tar has long been part of the comprehensive tobacco control strategy in Australia. This focus on tar has given an implicit endorsement of the low-yield cigarette as a safer cigarette. Recently, however, controversy has emerged about whether smoking low-yield cigarettes has reduced the harm done by smoking. The concern is that adenocarcinoma of the lung, a type of lung cancer that is most common in the small peripheral airways, has increased in frequency. This could be because the low-yield cigarette, with reduced yields of nicotine as well as tar, is smoked more intensely by smokers to compensate for the low nicotine. By smoking more intensely, we mean taking larger and more frequent puffs, inhaling the smoke deeply into the lungs, and holding the breath before expiring. This method of smoking would result in more tar particles being deposited in the peripheries of the lung where adenocarcinoma is most common. Because cigarette smoking has been linked also with other structural changes in the small airways of the lung, resulting in obstruction of airflow, we will test whether smoking low-yield cigarettes is associated with greater obstruction of the small airways than is smoking higher-yield cigarettes. To test whether the mechanism is the method of smoking, we will carefully describe and quantify each subject's pattern of smoking including the deposition of smoke-like Technegas particles in the peripheral lung.Read moreRead less
Reducing Tobacco Harm During Pregnancy, Infancy And Early Childhood Among Groups With High Smoking Prevalence
Funder
National Health and Medical Research Council
Funding Amount
$346,449.00
Summary
This research will contribute to the evidence base for reducing harm from tobacco during pregnancy, infancy and early childhood, among groups with high smoking prevalence. It will: generate evidence on a program to help pregnant Indigenous women quit smoking; develop tools and evidence to support implementation of smoking cessation guidelines in public antenatal services; and explore people’s understanding regarding protecting children from harms of passive smoking at home.
Randomised Trial Of A GP-initiated Tobacco Control Intervention With Arabic-speaking Smokers
Funder
National Health and Medical Research Council
Funding Amount
$232,000.00
Summary
Previous estimates of smoking rates among Arabic-speakers men and women range from 43% to 55%. No intervention has been designed specifically to target smoking in this community. Barriers to smoking cessation among Arabic-speakers are poorly understood. GPs find it difficult to counsel smokers about their smoking. Even when they do, they are as likely to use ineffective strategies. An alternative approach is referral of smokers by GPs to a smoking cessation skilled in evidence-based behavioural ....Previous estimates of smoking rates among Arabic-speakers men and women range from 43% to 55%. No intervention has been designed specifically to target smoking in this community. Barriers to smoking cessation among Arabic-speakers are poorly understood. GPs find it difficult to counsel smokers about their smoking. Even when they do, they are as likely to use ineffective strategies. An alternative approach is referral of smokers by GPs to a smoking cessation skilled in evidence-based behavioural strategies to facilitate abstinence. Therefore, we propose to conduct a randomised controlled trial to assess the effectiveness of referral of smokers attending general practices who offer consultation in Arabic to an Arabic-speaking counsellor for intensive support to improve quit rates at six and twelve months. We also will assess the acceptability of the intervention to smokers and GPs. Participating Arabic-speaking GPs in SWS will refer to the study about 1050 Arabic men and women aged between 18 and 65 years who self-report being current smokers. Participants will receive either intensive smoking cessation intervention or usual care provided by their GPs and self-help written information. The Intensive intervention will involve usual care by GPs and intensive smoking cessation counselling program that will involve series of scheduled telephone calls from an Arabic-speaking counsellor trained in smoking cessation counselling; printed self-help material in Arabic script and also will be offered a home visit and face-to-face counselling session. Results from this randomised trial will add to the scarce literature about smoking cessation among ethnic CALD minorities in Australia and overseas. If proven to be effective, a new choice will have been emerged to achieve optimal tobacco control in ethnic minorities in general practice. Divisions could consider employing bilingual counsellors as a resource for all GPs in their region.Read moreRead less